These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 21419164)
21. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination. Zhang Z; Wang Y; Fan H; Lu C Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391 [TBL] [Abstract][Full Text] [Related]
22. Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination. Chrun T; Maze EA; Vatzia E; Martini V; Paudyal B; Edmans MD; McNee A; Manjegowda T; Salguero FJ; Wanasen N; Koonpaew S; Graham SP; Tchilian E Front Immunol; 2021; 12():758368. PubMed ID: 34858411 [TBL] [Abstract][Full Text] [Related]
23. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls. Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422 [TBL] [Abstract][Full Text] [Related]
24. Phenotypic Characterization of Porcine IFNγ-Producing Lymphocytes in Porcine Reproductive and Respiratory Syndrome Virus Vaccinated and Challenged Pigs. Li X; Pei Z; Bai Y; Wang L; Shi J; Tian K Virol Sin; 2018 Dec; 33(6):524-530. PubMed ID: 30560415 [TBL] [Abstract][Full Text] [Related]
25. Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins. Zhu B; He T; Gao X; Shi M; Sun H Immunol Invest; 2019 Apr; 48(3):283-302. PubMed ID: 30325683 [TBL] [Abstract][Full Text] [Related]
26. Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine. Piras F; Bollard S; Laval F; Joisel F; Reynaud G; Charreyre C; Andreoni C; Juillard V Viral Immunol; 2005; 18(2):381-9. PubMed ID: 16035950 [TBL] [Abstract][Full Text] [Related]
27. Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs. Binjawadagi B; Lakshmanappa YS; Longchao Z; Dhakal S; Hiremath J; Ouyang K; Shyu DL; Arcos J; Pengcheng S; Gilbertie A; Zuckermann F; Torrelles JB; Jackwood D; Fang Y; Renukaradhya GJ Arch Virol; 2016 Jun; 161(6):1579-89. PubMed ID: 27008569 [TBL] [Abstract][Full Text] [Related]
28. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20. Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004 [TBL] [Abstract][Full Text] [Related]
29. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain. Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868 [TBL] [Abstract][Full Text] [Related]
30. Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective. Renukaradhya GJ; Dwivedi V; Manickam C; Binjawadagi B; Benfield D Anim Health Res Rev; 2012 Jun; 13(1):21-37. PubMed ID: 22717576 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420 [TBL] [Abstract][Full Text] [Related]
32. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge. Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217 [TBL] [Abstract][Full Text] [Related]
33. Systems Immunology Analyses Following Porcine Respiratory and Reproductive Syndrome Virus Infection and Vaccination. Bocard LV; Kick AR; Hug C; Lischer HEL; Käser T; Summerfield A Front Immunol; 2021; 12():779747. PubMed ID: 34975868 [TBL] [Abstract][Full Text] [Related]
34. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection. Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653 [TBL] [Abstract][Full Text] [Related]
35. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection. Renson P; Fablet C; Andraud M; Normand V; Lebret A; Paboeuf F; Rose N; Bourry O Vaccine; 2019 Jul; 37(31):4318-4324. PubMed ID: 31248683 [TBL] [Abstract][Full Text] [Related]
36. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions. Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022 [TBL] [Abstract][Full Text] [Related]
37. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge. Charerntantanakul W; Pongjaroenkit S Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999 [TBL] [Abstract][Full Text] [Related]
38. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2. Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631 [TBL] [Abstract][Full Text] [Related]
39. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines. Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1). Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]